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Toll-like receptor (TLR) responses are regulated to
avoid toxicity and achieve coordinated responses
appropriate for the cell environment. We found that
Notch and TLR pathways cooperated to activate ca-
nonical Notch target genes, including transcriptional
repressors Hes1 and Hey1, and to increase produc-
tion of canonical TLR-induced cytokines TNF, IL-6,
and IL-12. Cooperation by these pathways to in-
crease target gene expression was mediated by the
Notch-pathway component and transcription factor
RBP-J, which also contributed to lethality after endo-
toxin injection. TLR- and Notch-induced Hes1 and
Hey1 attenuated IL-6 and IL-12 production. This
Hes1- and Hey1-mediated feedback inhibitory loop
was abrogated by interferon-g (IFN-g), which
blocked TLR-induced activation of canonical Notch
target genes by inhibiting Notch2 signaling and
downstream transcription. These findings identify
new immune functions for RBP-J, Hes, and Hey pro-
teins and provide insights into mechanisms by which
Notch, TLR, and IFN-g signals are integrated tomod-
ulate specific effector functions in macrophages.
INTRODUCTION
Toll-like receptors (TLRs) recognize conserved microbial struc-
tures and are important in activating innate immunity and regu-
lating the transition from innate to acquired immune responses.
Activation of macrophages with TLR ligands leads to production
of inflammatory cytokines such as TNF and interleukin-1 (IL-1)
and also cytokines of the IL-6 and IL-12 family, namely IL-6,
IL-12, IL-23, and IL-27, that regulate T cell differentiation (Medz-
hitov, 2007). TLR2 and TLR4 recognize bacterial lipopeptides
and lipopolysaccharides (LPSs) and induce cytokine production
via the downstream signaling molecules IkB kinases (IKKs) and
mitogen-activated protein kinases (MAPKs), which in turn acti-
vate transcription factors nuclear factor kappa B (NF-kB) andactivator protein-1 (AP-1) (Kawai and Akira, 2007). In addition,
emerging evidence suggests that TLRs also regulate transcrip-
tion by inducing chromatin modifications in a gene-specific man-
ner (Anest et al., 2003; Saccani et al., 2002; Yamamoto et al.,
2003).
Unrestrained activation of TLR responses can lead to exces-
sive inflammation and tissue damage and contribute to patho-
genesis of inflammatory disorders such as septic shock. There-
fore, TLR signaling is subject to negative regulation and
feedback inhibition (Liew et al., 2005). TLRs induce expression
of counter-regulatory cytokines such as IL-10 and numerous sig-
naling inhibitors (Lang and Mansell, 2007). TLRs also induce ex-
pression of transcriptional repressors, such as ATF3, that feed
back and suppress expression of specific subsets of TLR-induc-
ible genes (Gilchrist et al., 2006). In addition, TLRs induce
remodeling and posttranslational modification of chromatin
(histone ‘‘marks’’) that can either activate or silence gene ex-
pression (Foster et al., 2007; Ramirez-Carrozzi et al., 2006;
Saccani et al., 2002). Silencing by such epigenetic modifications
during endotoxin tolerance, which is probably mediated by tran-
scriptional repressors (Foster et al., 2007), plays a key role in
specifically restraining potentially toxic inflammatory cytokine
expression while allowing beneficial expression of host defense
genes. Thus, selective regulation of subsets of TLR-inducible
genes allows fine-tuning of distinct biological functions induced
by TLRs.
The Notch signaling pathway regulates cell differentiation,
proliferation, survival, and development. In mammalian cells,
there are four Notch receptors (Notch 1–4) and five Notch ligands
(Jagged1, Jagged2, Delta-like 1 [DLL1], DLL3, and DLL4). Liga-
tion of Notch receptors by their ligands leads to a two-step pro-
teolytic cleavage of Notch by a disintegrin and metalloprotease
(ADAM) family proteases and the intracellular g-secretase com-
plex that releases the Notch intracellular domain (NICD). NICD
translocates to the nucleus and binds to the DNA-binding protein
recombinant-recognition-sequence-binding protein at the Jk
site (RBP-J, also named CSL or CBF1). This interaction results
in displacement of RBP-J-associated transcriptional corepres-
sors and assembly of a transcriptional activation complex that
drives expression of Notch target genes (Bray, 2006). Among
the best-characterized direct Notch target genes are hairy andImmunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc. 691
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YRPW motif (Hey) families of basic helix-loop-helix transcrip-
tional repressors. Hes and Hey proteins function as feedback in-
hibitors of Notch-induced gene expression (Fischer and Gessler,
2007). Although RBP-J plays a key role in canonical Notch signal
transduction, Notch can signal independently of RBP-J and
RBP-J can be activated by alternative signaling pathways (Mar-
tinez Arias et al., 2002).
In the immune system, Notch signaling regulates multiple
steps of T and B cell development (Tanigaki and Honjo, 2007),
T cell activation (Eagar et al., 2004), regulatory T cell function
(Ostroukhova et al., 2006), and T helper cell differentiation (Am-
sen et al., 2007; Amsen et al., 2004; Fang et al., 2007; Maillard
et al., 2005; Osborne and Minter, 2007; Skokos and Nussenz-
weig, 2007). Notch ligands and receptors are induced on den-
dritic cells and macrophages by TLRs and various stimuli, and
previous work has demonstrated a role for antigen-presenting
cell (APC)-expressed DLL in promoting T helper 1 (Th1) cell
and Jagged in promoting Th2 cell differentiation. Investigation
of Notch responses has focused predominantly on lymphocytes,
and knowledge about the effects of Notch signaling in myeloid
lineage cells is more limited. The Notch pathway has been impli-
cated in dendritic cell (DC) differentiation and survival (Caton
et al., 2007; Ohishi et al., 2001; Weijzen et al., 2002; Yamada
et al., 2003), and TLRs have been suggested to indirectly activate
noncanonical Notch pathways leading to NF-kB activation and
TNF production by inducing Notch receptor and ligand expres-
sion on myeloid cells (Fung et al., 2007; Monsalve et al., 2006;
Palaga et al., 2008).
The potent macrophage activating cytokine IFN-g synergizes
with TLRs to induce augmented production of inflammatory cy-
tokines (Schroder et al., 2004). Mechanisms underlying this syn-
ergy and crosstalk between IFN-g and TLR responses have not
been resolved and are under active investigation. We previously
demonstrated that IFN-g suppresses TLR-induced expression
of AP-1 proteins and IL-10 (Hu et al., 2007; Hu et al., 2006). In
this study, we investigated whether IFN-g suppresses expres-
sion of subsets of TLR-inducible genes that can be distin-
guished by their functions or regulatory requirements. We dis-
covered that in primary macrophages TLRs rapidly induced
expression of canonical Notch target genes, including the tran-
scriptional repressors Hes1 and Hey1, by a direct mechanism
that did not require upregulation of Notch receptors or ligands.
Robust gene expression required synergy between TLR and ca-
nonical Notch pathways and thus the Notch pathway regulates
expression of a subset of TLR-inducible genes. IFN-g inhibited
expression of these Notch-dependent TLR-inducible genes by
suppressing intracellular NICD2 and subsequent Notch-depen-
dent transcription, thus revealing a new mechanism by which
IFN-g inhibits gene expression. Furthermore, by using a genetic
approach we demonstrated that RBP-J contributed to TLR-
mediated production of IL-6 and IL-12. Production of IL-6 and
IL-12 family cytokines was suppressed by Hes1 and Hey1,
thereby revealing a new TLR-induced feedback inhibitory
loop and identifying a function of Hes1 and Hey1 in immunity.
Overall, our results identify direct cooperation between TLR
and Notch pathways that is modulated by IFN-g to regulate
specific components of TLR responses with distinct biological
functions.692 Immunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc.RESULTS
TLRs Directly Induce Expression of Canonical Notch
Target Genes
We extended our previous analysis of IFN-g-mediated inhibition
of TLR-induced gene expression (Hu et al., 2007; Hu et al., 2006)
by using microarray analysis to define the subset of TLR-induc-
ible genes that are inhibited by IFN-g in primary human macro-
phages. Strikingly, the group of TLR-induced and IFN-g-sup-
pressed genes included the well-established Notch target
genesHES1,HEY1, IL2RA, IL7R,BATF, andMYC (Table S1 avail-
able online). These genes contain RBP-J sites in their promoters
and are direct targets of the Notch pathway (Adler et al., 2003;
Garcia-Peydro et al., 2006; Johansen et al., 2003; Maier and
Gessler, 2000; Maillard et al., 2005; Nakagawa et al., 2000;
Weng et al., 2006). Although IL2RA, IL7R, BATF, and MYC ex-
pression is known to be induced by many pathways, expression
of HES1 and HEY1 is regulated predominantly by Notch in most
systems (Louvi and Artavanis-Tsakonas, 2006), and the functions
of these proteins in immune responses remain to be determined.
Activation of Notch-target-gene expression by TLR ligands
was analyzed with quantitative real-time PCR. Robust induction
of BATF, HES1, HEY1, IL2RA, and IL7R mRNA was consistently
observed in primary human macrophages derived from more
than 20 blood donors, although the amount of induction relative
to baseline expression was variable among different blood do-
nors (a representative experiment using LPSs is shown in
Figure 1A). Expression of the canonical Notch target genes
HES1 and HEY1 was effectively induced by Pam3Cys (a TLR2
ligand), LPSs (TLR4 ligand), and R848 (TLR7-TLR8 ligand)
(Figure 1B), indicating that activation of Notch target genes is
a common feature of macrophage TLR responses. Induction of
HES1 and HEY1 mRNA was apparent 0.5 hr after LPS stimula-
tion, and amounts of mRNA increased in a time-dependant man-
ner with somewhat faster kinetics for HES1 (Figure 1C); in some
donors an oscillatory but progressively increasing pattern of
HES1expression was observed, consistent with previous reports
(Hirata et al., 2002; Yoshiura et al., 2007) (Figure S1). Induction of
nuclear Hes1 protein was observed in macrophages treated for 6
hr with LPSs (Figure 1D) and Pam3Cys (data not shown). These
results show that TLRs induce expression of Notch target genes,
including the canonical Notch targets HES1 and HEY1 that are
widely used as reporters of Notch-pathway activity.
TLRs induce expression of Notch ligands and receptors
(Amsen et al., 2004; Fung et al., 2007; Monsalve et al., 2006;
Palaga et al., 2008), which could potentially mediate indirect
TLR-induced expression of Notch target genes. However, induc-
tion of HES1, HEY1, IL2RA, IL7R, and MYC by LPSs occurred
prior to induction of cell-surface expression of Notch ligands
(data not shown) and was intact in the presence of the protein
synthesis inhibitor cycloheximide (CHX) (Figure 1E), and thus
did not require de novo synthesis of Notch ligands or other pro-
teins. These results show direct activation of Notch target genes
by TLR pathway.
TLR-Induced Gene Expression Is Regulated by the
Notch Pathway
We next tested the regulation of Notch signaling in human
macrophages and whether TLR-induced activation of Notch
Immunity
Integration of Notch, TLR, and IFN-g Signalingtarget genes is dependent on the Notch pathway. Notch activa-
tion involves proteolytic release of NICD by the g-secretase
complex, and thus expression of NICD is used to monitor
Notch-pathway activity. Human macrophages constitutively
expressed Notch1, Notch2, Jagged1, and DLL1, with minimal
or no detectable expression of other Notch receptors or ligands
(data not shown). Consistent with basal expression of ligands
and receptors and previous observations of basal Notch activity
in macrophages and DCs in vivo (Caton et al., 2007), we
Figure 1. TLRs Induce Notch-Target-Gene
Expression
(A) Human primary macrophages were stimulated
with 10 ng/ml of LPSs for 3 hr. mRNA expression
of the indicated genes was measured by quantita-
tive real-time PCR and normalized relative to
glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) mRNA. Relative expression was calcu-
lated by setting expression of untreated samples
as 1. Data are shown as means + SD of triplicate
determinants and are representative of more
than 20 experiments using cells derived from dif-
ferent human donors.
(B) Human macrophages were treated with the in-
dicated TLR agonists for 3 hr. Hes1 and Hey1
mRNA was measured by real-time PCR. Data are
shown as means + SD of triplicate determinants
and are representative of two independent exper-
iments.
(C) Human macrophages were stimulated with
10 ng/ml of LPSs for the indicated periods. Data
are shown as means + SD of triplicate determi-
nants and one representative experiment out of
three is shown.
(D) Human macrophages were treated with
10 ng/ml of LPSs for 6 hr. Nuclear extracts were
analyzed with immunoblotting with antibodies
against Hes1 and then by probing the same filter
with antibodies against TBP. One representative
experiment out of five performed is shown.
(E) Human macrophages were treated with
15 mg/ml CHX prior to stimulation with 10 ng/ml
of LPSs for 3 hr, and mRNA of the indicated genes
was measured with real-time PCR. Data are shown
as means + SD of triplicate determinants and are
representative of four independent experiments.
detected basal Notch activity, as evi-
denced by expression of NICD1 and
NICD2 (Figure 2A, lane 1, and Figure
S2B, lane 1). The basal expression of
NICD1 was suppressed by two different
g-secretase inhibitors, compound E and
L685458 (Figure 2A, lanes 3 and 4), con-
sistent with basal activation of Notch
receptors in human macrophages. Basal
Notch signaling was also manifested by
basal expression of low amounts of
HES1 and HEY1 mRNA (data not
shown). LPS stimulation did not increase
expression of NICD1 or NICD2 above
baseline amounts within the time frame
of these experiments, 1–6 hr of stimula-
tion in which robust induction of Notch target genes was ob-
served (Figure 2A, lane 2 and Figure S2). Similar results were
obtained when cells were treated with Pam3Cys (data not
shown). These data show that TLR signals did not directly acti-
vate canonical Notch signaling and suggest that TLRs may
engage a parallel pathway that works together with Notch-
mediated signals to induce the early phase of Notch-target-
gene expression, which occurs independently of new protein
synthesis.Immunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc. 693
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Integration of Notch, TLR, and IFN-g SignalingFigure 2. Notch Signaling Is Necessary for TLR Induction of Notch Target Genes
(A) Human macrophages were activated with 10 ng/ml of LPSs for 1 hr (lane 2) or incubated with either g-secretase inhibitors Compound E (Comp E; 10 mM) or
L685458 (5 mM) (lanes 3 and 4). Whole-cell extracts were assayed for NICD1 by immunoblotting. Stat3 served as a loading control. One representative experiment
out of two performed is shown.
(B) Human macrophages were pretreated with DMSO vehicle control or g-secretase inhibitors for 2 days and subsequently stimulated with 10 ng/ml of Pam3Cys
for 3 hr. mRNA was measured by real-time PCR. Data are shown as means + SD of triplicate determinants and are representative of five independent experi-
ments.
(C and D) Primary human macrophages were transfected with control nontargeting or RBPJ-specific short interfering RNAs. Four days after transfection, cells
were stimulated with TLR ligands (10 ng/ml) for 3 hr, and mRNA was measured with real-time PCR. As shown in (C), macrophages were activated with Pam3Cys.
One representative experiment out of three performed is shown. Results are presented as means + SD of triplicate determinants. As shown in (D), macrophages
were stimulated with LPSs. The percentage of maximal expression was calculated relative to mRNA amounts in LPS-stimulated control cells, and data are ex-
pressed as means + SD of three independent experiments.
(E) Bone-marrow-derived macrophages from Rbpjflox/flox (f/f) mouse and Rbpjf/f, Cre/Cre littermate controls were stimulated with 1 ng/ml of LPSs for the indicated
periods. RNA was extracted and mRNA was measured with real-time PCR. Unstimulated controls within each genotype were set as 1. Data are shown as means
+ SD of triplicate determinants and are representative of three independent experiments. The difference inHes1 expression between control and RBP-J-deficient
macrophages at 6 hr was statistically significant (p = 0.004 by paired Student’s t test).We investigated the requirement for the Notch pathway in TLR-
induced gene activation by inhibiting g-secretase. Treatment of
macrophages with g-secretase inhibitors did not result in in-
creased cell death or altered morphology (data not shown) and
had minimal effects on TLR induction of IL8, a prototypical
NF-kB target gene (Figure 2B, right panel). Notably, two different
g-secretase inhibitors suppressed TLR-induced expression of
HES1, HEY1, IL2RA, and IL7R, suggesting that Notch signaling
was necessary for gene induction. To obtain additional evidence
supporting a role for the Notch pathway in gene activation, we
used RNA interference to knock down expression of RBP-J,694 Immunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc.a master regulator of Notch target genes, in primary human mac-
rophages. Although expression of Notch target genes was ro-
bustly induced in cells transfected with control, nontargeting
siRNA, knockdown ofRBPJ expression (Figure 2C, top left panel)
resulted in diminished activation ofHES1,HEY1, IL2RA, and IL7R
by Pam3Cys and LPSs (Figures 2C and 2D). These results were
corroborated with an additional nontargeting control siRNA and
two additional RBPJ-specific siRNAs (Figure S3). Induction of
IL1B by TLR2 was not affected by knockdown of RBPJ expres-
sion (Figure 2C, upper panels), showing that decreased RBPJ
expression did not result in global suppression of TLR responses.
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phages deficient in RBP-J. Because RBP-J-deficient mice are
not viable (Oka et al., 1995), we used macrophages from mice
with myeloid-specific deletion of the floxed Rbpj gene (Tanigaki
et al., 2002); these macrophages exhibited an approximately
80% reduction in RBP-J mRNA. Stimulation of control murine
macrophages (obtained from littermate controls) resulted in
a modest but reproducible increase in Hes1 expression (Fig-
ure 2E). This lower-amplitude induction of Hes1 is most likely
explained by low basal Notch receptor expression by murine
macrophages in vitro (Fung et al., 2007; Monsalve et al., 2006;
Palaga et al., 2008) and is consistent with amounts of Hes1 in-
duction observed in other murine systems (Hirata et al., 2002;
Yoshiura et al., 2007). Induction of Hes1 and also Il7r expression
by LPSs was abrogated in macrophages expressing low
amounts of RBP-J (Figure 2E). Overall, results obtained from
chemical-inhibitor studies, RNA interference, and gene-deficient
mice show that a subset of TLR-inducible genes is dependent on
components of the Notch signaling pathway.
Notch-Target-Gene Induction Is Dependent on
Canonical TLR Signaling Pathways
We next investigated the interplay between Notch and canonical
TLR signaling in the induction of Notch target genes in macro-
phages. Treatment of human macrophages with exogenous
Jagged1 or DLL1 to maximally engage Notch receptors resulted
in modest upregulation of HES1, HEY1, and IL7R expression rel-
ative to strong induction by LPSs (Figure 3A). IL6 was not in-
duced by Notch ligands, indicating that the induction of HES1,
HEY1, and IL7R by these factors was not secondary to contam-
ination with LPSs (Figure 3A, lower panel). These results suggest
that input from TLRs and synergy between Notch and TLR path-
ways is necessary to achieve full-scale activation of Notch target
genes in macrophages. This notion was further corroborated by
transfection experiments with a Hes1-promoter-driven reporter
gene (Ong et al., 2006). Cotransfection of RAW264.7 murine
macrophage-like cells that do not exhibit basal Notch activity
with the Hes1 reporter construct and NICD1 increased reporter
gene activity, as expected (Figure 3B). Hes1-promoter activity
was augmented when cells were stimulated with LPSs only
when NICD was expressed (Figure 3B), further supporting the
notion that both Notch and TLR signals are required for maximal
gene induction and that these signals interact independently of
Notch-ligand induction.
To delineate the pathway by which TLRs induce Notch target
genes, we applied chemical inhibitors of TLR signaling compo-
nents to human primary macrophages prior to stimulation. Within
the time frame of these experiments (3 hr), no apparent cell death
or toxicity was observed with inhibitor treatments, and the effi-
cacy of inhibitors was verified by their ability to suppress known
TLR-inducible NF-kB and MAPK target genes such as IL6 and
MKP1 (data not shown). Pharmacological inhibition of IKKs or
the p38 MAPK consistently attenuated TLR-mediated induction
of Notch target genes such asHES1, IL2RA, and IL7R (Figure 3C,
Figure S4, and Table S2). To further establish a role for IKKs and
p38 in gene induction, we used RNAi to knock down compo-
nents of these pathways in human macrophages and also
used macrophages from gene-deficient mice. Knockdown of
IKKa did not alter HES1 induction (data not shown), whereasknockdown of IKKb (Figure 3D, left panel) strongly attenuated
TLR-stimulated HES1 expression (Figure 3D). MEKK3 is
a MAPKKK required for p38 activation downstream of TLRs
(Huang et al., 2004). RNA interference-mediated MEKK3 knock-
down resulted in reduced LPS-induced HES1 expression
(Figure 3E). Furthermore, HES1 induction was abolished in mac-
rophages with targeted deletion of the Mapk14 gene that en-
codes p38a (Figure 3F), an isoform of p38 that is critical for
TLR responses in myeloid cells (Kang et al., 2008). Thus, both
pharmacological and genetic evidence demonstrated that
expression of Notch target genes was induced by TLR signaling
via IKKb- and p38-dependent pathways that worked in
collaboration with basal Notch signals. Induction of IL2RA and
IL7R genes by IKK- and MAPK-dependent pathways is well
established, but a role for these pathways in inducing ‘‘dedi-
cated’’ Notch target genes such as Hes1 has not been previously
appreciated.
Next, we investigated the pathways downstream of IKKs and
p38 that lead to Hes1 activation. We chose to study Hes1 be-
cause it is a classic Notch target gene and was very sensitive
to MAPK and IKK inhibition. Hes1 is not known to be regulated
by NF-kB or p38-activated transcription factors (Bray, 2006),
and thus we examined phosphorylation of histone H3 at serine
10, a histone modification that is induced by both IKKs and
p38 and is linked with recruitment of RNA polymerase II and
transcriptional activation (Anest et al., 2003; Saccani et al.,
2002; Yamamoto et al., 2003). Chromatin immunoprecipitation
(ChIP) assays with primary human macrophages showed that
TLR stimulation induced phosphorylation of histone H3 on serine
10 at the HES1 promoter (Figure 3G). This inducible phosphory-
lation was substantially reduced in macrophages treated with in-
hibitors of IKKs or p38, whereas these inhibitors did not alter total
histone H3 occupancy on the HES1 promoter (Figure 3H). Taken
together, the results support a link between TLR signaling and
the HES1 locus and imply that TLRs contributed to Notch-tar-
get-gene activation in part by inducing histone H3 phosphoryla-
tion (Berger, 2007).
IFN-g Inhibits Notch Responses in Macrophages
One striking characteristic of TLR-inducible Notch target genes
is that they are suppressed by IFN-g (Table S1 and Figure 4A),
and we wished to further characterize the effects of IFN-g.
IFN-g-mediated inhibition of Hes1 protein expression was con-
firmed by immunoblotting (Figure 4B). To determine whether
IFN-g affects transcription or posttranscriptional regulation, we
measured expression of primary transcripts, a well-accepted
measure of transcription rate (Murray, 2005). IFN-g suppressed
basal expression of HES1 and HEY1 primary transcripts
(Figure 4C), thereby showing that IFN-g inhibited Notch-depen-
dent transcription. The addition of LPSs resulted in additional
RNA polymerase II recruitment to the HES1 promoter, and poly-
merase recruitment was suppressed by IFN-g (Figure 4D). These
results suggest that IFN-g targets the Notch pathway and sup-
presses Notch-dependent transcription.
Next, we investigated the mechanisms by which IFN-g inhibits
TLR-inducible and Notch-dependent responses. Because IFN-g
does not attenuate and could augment canonical TLR4-induced
signaling (Hu et al., 2005), we reasoned that IFN-gmay inhibit the
Notch pathway. This notion was tested by examining the effectsImmunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc. 695
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Integration of Notch, TLR, and IFN-g SignalingFigure 3. TLRs Contribute to Notch-Target-Gene Activation by IKK- and p38-Dependent Pathways
(A) Human macrophages were treated with 10 mg/ml of Jagged1-Fc, cocultured with OP9-DL1 cells, or stimulated with 10 ng/ml of LPSs for 3 hr. mRNA was
measured by real-time PCR. Similar results were obtained when cells were treated with plate-bound Jagged1-Fc. Results are shown as means + SD of triplicate
determinants and are representative of three independent experiments.
(B) RAW264.7 cells were cotransfected with a Hes1 reporter gene construct and an expression plasmid encoding NICD1 or a control empty vector. One day after
transfection, cells were stimulated with 1 mg/ml of LPSs for 6 hr. Results were shown as normalized firefly luciferase activity relative to internal control and
expressed as mean + SD from duplicate transfections. One representative experiment out of four performed is shown.
(C) Human macrophages were pretreated with DMSO vehicle control, 10 mM of Bay11-7082 (Bay11), or 10 mM of SB203580 for 30 min and stimulated with
10 ng/ml of LPSs for 3 hr. mRNA was measured with real-time PCR. Results are shown as means + SD of triplicate determinants and are representative of seven
independent experiments.
(D and E) Primary human macrophages were transfected with control or IKKb-specific siRNAs (D) or MEKK3-specific siRNAs (E) with an Amaxa nucleofector. Four
days after transfection, cells were stimulated with LPSs (10 ng/ml) for 3 hr, and mRNA was measured with real-time PCR. Data are shown as means + SD of
triplicate determinants and are representative of three independent experiments.
(F) Bone-marrow-derived macrophages from control or Mapk14-deficient mice were stimulated with 10 ng/ml of LPSs for the indicated time periods. mRNA was
measured with real-time PCR. Unstimulated controls within each genotype were set as 1. Data shown as means + SD of triplicate determinants and one exper-
iment representative of two is shown.
(G) ChIP was performed with LPS-treated primary human macrophages with anti-phospho-serine 10 histone H3 (pSer10-H3) or rabbit IgG as a control. Immu-
noprecipitated DNA was analyzed by semiquantitative PCR with Hes1-promoter-specific primers.
(H) ChIP was done as in (G) with 30 min preincubation of inhibitors and 2 hr of Pam3Cys stimulation. Data in (G) and (H) are representative of three independent
experiments.of IFN-g on basal Notch signaling. IFN-g did not inhibit Notch1 or
Notch2 mRNA expression (data not shown), and we then as-
sessed the effects of IFN-g on amounts of NICD1 and NICD2,
proteolytic fragments of Notch that mediate transcriptional acti-
vation. IFN-g had minimal effects on the amounts of NICD1
(Figure S5A) but strikingly decreased cellular NICD2 amounts
(Figure 4E) without suppressing full-length Notch2 protein ex-
pression (Figure S5B). Decreased NICD2 would be predicted
to result in diminished histone acetylation at Notch target pro-
moters (Bray, 2006). Indeed, we found that IFN-g suppressed696 Immunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc.H3 K9K14 acetylation at the HES1 locus (Figure 4F, lane 8),
whereas methylation of H3 K27 or phosphorylation of H3 serine
10 were not affected (data not shown). These results indicate
that IFN-g blocked Notch signaling at least in part by suppress-
ing NICD2, the active fragment of the most highly expressed
Notch receptor in human macrophages. The notion that IFN-g
suppressed the Notch pathway was supported by evidence
that IFN-g inhibited the induction of HES1 and HEY1 expression
by the Notch ligands Jagged1 and DLL1 (Figure 4G). Collec-
tively, these results indicate that IFN-g targets the Notch
Immunity
Integration of Notch, TLR, and IFN-g SignalingFigure 4. IFN-g Inhibits Notch Responses in Macrophages
(A) Human macrophages were primed with 100 U/ml of IFN-g for the indicated periods and stimulated with 10 ng/ml of LPSs for 3 hr. mRNA was measured with
real-time PCR.
(B) Human macrophages were treated with IFN-g (100 U/ml) overnight and stimulated with 10 ng/ml of LPSs, and nuclear Hes1 protein was measured by immu-
noblotting.
(C) Human macrophages were left untreated or treated with 100 U/ml of IFN-g overnight. Primary transcripts were measured with real-time PCR.
(D) Control or IFN-g primed human macrophages were stimulated with 10 ng/ml of LPSs for 2 hr. RNA polymerase II (RNA Pol II) recruitment to Hes1 promoter was
assessed by ChIP.
(E) Control or IFN-g primed human primary macrophages were stimulated with 10 ng/ml of LPSs for 6 hr. Whole-cell extracts were subjected to immunoblotting
with an antibody that recognizes NICD2 (upper panel). The same filter was blotted with SHP2 antibody (lower panel).
(F) Control or IFN-g primed human macrophages were stimulated with 10 ng/ml of LPSs for 2 hr. Histone H3 K9K14 acetylation at the HES1 locus was assessed
by ChIP.
(G) Human control or IFN-g-treated macrophages were stimulated with Notch ligands for 3 hr. mRNA was measured by real-time PCR. Data in (A)–(G) are rep-
resentative of at least three independent experiments; in (A), (C), and (G), data are shown as means + SD of triplicate determinants.pathway by inhibiting Notch signaling and downstream Notch-
dependent transcription.
Role of Notch Component RBP-J in TLR-Induced
Cytokine Responses
Having identified a role of TLR signaling in regulation of canonical
Notch target genes, we sought to investigate the reciprocal reg-
ulation, namely the role of Notch components in canonical TLR
responses such as inflammatory cytokine production. Notch ac-
tivity has been suggested to augment NF-kB activation and TNF
production in TLR-activated macrophages based upon experi-
ments using g-secretase inhibitors and RNAi-mediated suppres-
sion of Notch expression in RAW264.7 cells (Fung et al., 2007;
Palaga et al., 2008). We confirmed and extended these results
by using a genetic approach showing that deletion of RBP-J in
the myeloid compartment protected mice from endotoxin lethal-
ity in vivo and attenuated TLR-induced TNF production in vitro(Figure 5A). A comparable suppression of TLR-induced TNF pro-
duction was observed in human macrophages when RBPJ
expression was knocked down with RNAi (Figure S6B). These re-
sults support a physiological role for the Notch pathway in TLR
responses. Next, we wished to determine whether RBP-J regu-
lates expression of cytokines other than TNF. IL-6 and IL-12 pro-
tein production was decreased in Rbpj-deficient macrophages
in response to LPS stimulation (Figure 5B), and a similar de-
crease in IL-6 production was observed in human macrophages
when RBPJ expression was knocked down (Figure S6B). In con-
trast,Rbpj deficiency did not affect TLR induction of IL-1bmRNA
(Figure 5C), consistent with the unaltered IL-1b expression in
RBP-J-low human macrophages (Figure 3A). Constitutive bind-
ing of RBP-J to a conserved binding sequence in the Il6 promoter
has been reported (Plaisance et al., 1997), suggesting a direct
regulation of Il6 expression by RBP-J. Consistent with this no-
tion, we found that a mutation that selectively blocks bindingImmunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc. 697
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Integration of Notch, TLR, and IFN-g SignalingFigure 5. RBP-J Contributes to TLR-Induced Cytokine Production
(A) Decreased TNF production and attenuated endotoxin lethality in RBP-J-deficient macrophages and mice with myeloid-specific deletion of Rbpj. As shown in
the upper panel, 6- to 8-week-old Rbpjflox/flox (f/f) and Rbpjf/f, Cre/Cre littermates were intraperitoneally injected with 1 mg of LPSs and survival of animals was
monitored over time. As shown in the lower panel, bone-marrow-derived macrophages from Rbpjf/f mouse and Rbpjf/f, Cre/Cre littermate controls were stimu-
lated with 1 ng/ml of LPSs for the indicated periods. TNF protein amounts in culture supernatants were measured with ELISA.
(B) Control and RBP-J-deficient bone-marrow-derived macrophages were stimulated with 1 ng/ml of LPSs for the indicated periods. IL-6 and IL-12p70 protein in
culture supernatants were measured with ELISA. Data are representative of three independent experiments.
(C) Bone-marrow-derived macrophages were stimulated with 1 ng/ml of LPSs for the indicated periods, and IL-1bmRNA was assessed with real-time PCR. Data
are shown as means + SD of triplicate determinants and are representative of at least three independent experiments.
(D) RAW264.7 cells were cotransfected with an IL-6-reporter construct containing 221 bases of the proximal wild-type IL-6 promoter or a construct with a T/G
point mutation within the RBP-J binding site, at position 70 relative to the transcription start site. Twenty-four hours after transfection, cells were stimulated with
1 mg/ml of LPSs for 6 hr, and cell lysates were analyzed for luciferase activity. Results are presented as average relative luciferase activities of three independent
experiments.of RBP-J to the Il6 promoter (Plaisance et al., 1997) diminished
LPS-induced Il6 promoter-driven reporter-gene activity
(Figure 5D). Thus, a role for RBP-J in mediating TLR induction
of Il6 expression is supported by gene deletion, RNAi, and
promoter mutagenesis data. Overall, these results show that
RBP-J contributes to TLR-induced cytokine gene expression
and further support direct cooperation between Notch and
TLR pathways in gene regulation.
Feedback Inhibition of Cytokine Production
by Hes1 and Hey1
Hes1 and Hey1 function as feedback inhibitors and repressors of
Notch-induced gene activation. The net effects of the Notch
pathway on TLR responses will be determined by the balance
between responses directly activated via RBP-J and the effec-
tiveness and specificity of feedback inhibitors such as Hes1
and Hey1. We next tested the hypothesis that Hes1 and Hey1
may feed back and attenuate TLR-induced cytokine production.
To study the intrinsic effects of the Hey1 gene in the hematopoi-
etic compartment, we generated chimeric mice by reconstituting
lethally irradiated recipients with wild-type orHey1/ bone mar-
row cells (Fischer et al., 2004). Pam3Cys-induced peritoneal ex-
udates were significantly increased in Hey1 null bone marrow
chimeras (Figure 6A), indicating an important role for Hey1 in reg-698 Immunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc.ulating TLR-induced inflammation in vivo. To further characterize
the role of Hey1 in TLR responses, we stimulated bone-marrow-
derived macrophages from chimeric mice with Pam3Cys and
measured gene expression and cytokine production. Hey1 defi-
ciency minimally affected TLR2-induced expression of Tnf or Il10
(Figure 6B). In contrast, TLR2-induced expression of IL-6 and
IL-12 family cytokine genes, including Il6, Il12p40, Il12p35, and
Il27p28, was elevated in Hey1 null macrophages (Figure 6B).
The mRNA expression patterns were corroborated when the
amounts of secreted IL-10, TNF, IL-6, and IL-12p70 proteins
were measured (Figure 6C). These results demonstrate that
Hey1 functions as a feedback inhibitor of TLR2-induced produc-
tion of IL-6 and IL-12 family cytokines.
Hes and Hey proteins suppress gene expression by a number
of mechanisms that include binding to N boxes or suppressing
E box-mediated transcription in promoters that contain tandem
E boxes and RBP-J sites (Fischer and Gessler, 2007; Iso et al.,
2003; Tanigaki and Honjo, 2007). We investigated the mecha-
nism by which Hey1 inhibits IL-6 expression by analyzing the ef-
fects of Hey1 on the activity of an IL-6-promoter-driven reporter
gene. We found that Hey1 suppressed TLR-induced activation of
an IL-6 promoter-driven reporter gene that contains 1300 bp of
promoter sequences in a dose-dependent manner in transient-
transfection assays (Figure 6D). These results show that Hey1
Immunity
Integration of Notch, TLR, and IFN-g SignalingFigure 6. Hey1 Inhibits IL-6 and IL-12 Family Cytokines and Regulates Inflammation In Vivo
(A) Peritonitis was induced in bone marrow chimeras reconstituted with Hey1+/+ or Hey1/ bone marrow cells by intraperitoneal injection of 100 mg of Pam3Cys
per mouse. One day after Pam3Cys administration, peritoneal cells were harvested and counted. The results are cumulative from two independent experiments,
and n = 7 in each group. The p value was calculated by unpaired Student’s t test.
(B) Bone-marrow-derived murine macrophages were generated from Hey+/+ or Hey/ bone marrow chimeras. Cells were stimulated with Pam3Cys, and mRNA
was measured by real-time PCR. Data are shown as means + SD of triplicate determinants and are representative of three independent experiments.
(C) Hey1+/+ or Hey1/ bone-marrow-derived macrophages were stimulated with Pam3Cys, and cytokine concentrations in culture supernatants were deter-
mined by ELISA. A representative experiment out of three performed is shown.
(D) RAW264.7 cells were cotransfected in duplicate with an IL-6-reporter construct containing 1300 bases of the proximal IL-6 promoter (full length) and a Hey1
expression plasmid or empty vector control. Twenty-four hours after transfection, cells were stimulated with 1 mg/ml of TLR agonists for 6 hr, and cell lysates were
analyzed for luciferase activity.
(E) Transfections of RAW264.7 cells were performed as in (D) with an IL-6-reporter construct containing 221 bases of the proximal wild-type IL-6 promoter or
a construct with point mutations within the E box sequence (CAAATG/ACAATG). In (D) and (E), data are shown as mean + SD from duplicate transfections
and are representative of three independent experiments.can suppress IL-6 promoter activity and suggest that transcrip-
tional repressors such as Hey1 may directly regulate cytokine
genes. The IL-6 promoter contains a potential N box sequence,
but deletion of the N box did not abrogate repression of the
IL-6 promoter by Hey1 (data not shown). The deletional analysis
thus excluded a role for the IL-6 promoter N box-like sequence
and mapped the target of Hey1 repression to 221 bases of the
proximal IL-6 promoter (Figure 6E, left). In addition to an RBP-J
site (Plaisance et al., 1997), the IL-6 promoter contains a putativeE box (81 to76 relative to transcription start site) and thus con-
forms to one type of promoter architecture that is inhibited by Hes
and Hey proteins. Site-directed mutagenesis showed that muta-
tion of the E box sequence abrogated the ability of Hey1 to inhibit
IL-6 promoter activity (Figure 6E). These results map in the IL-6
promoter the target sequence that mediates inhibition by Hey1
and suggest that Hey1 inhibits IL-6 expression by the established
mechanism of inhibiting E box-RBP-J-mediated transcription
(Fischer and Gessler, 2007; Tanigaki and Honjo, 2007).Immunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc. 699
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Integration of Notch, TLR, and IFN-g SignalingFigure 7. Hes1 Negatively Regulates IL-6 Expression
(A) Fetal-liver-derived macrophages from wild-type, Hes1-
haplodeficient, or Hes1-deficient embryos were stimulated
with 10 ng/ml of Pam3Cys. Cytokine mRNA expression was
determined by real-time PCR. Data are shown as means + SD
of triplicate determinants and are representative of two inde-
pendent experiments.
(B) IL-6 protein concentrations in supernatants of Pam3Cys-
stimulated fetal-liver-derived macrophages were analyzed
by ELISA. Results are representative of two independent ex-
periments.
(C) RAW264.7 cells were cotransfected in duplicate with the
full-length IL-6-reporter construct and a Hes1 expression
plasmid or empty vector control. Twenty-four hours after
transfection, cells were stimulated with 1 mg/ml of LPSs for
6 hr, and cell lysates were analyzed for luciferase activity.
Data are shown as mean + SD from duplicate transfections
and are representative of three independent experiments.Next, we sought to evaluate the role of Hes1 in regulation of
TLR-induced cytokine production by using genetic approaches.
RNAi-mediated approaches were not successful in attenuating
TLR-induced Hes1 expression in human macrophages, and ab-
lation of Hes1 in mice results in embryonic or neonatal lethality,
and thus function of Hes1 can not be readily studied in the adult
immune system (Ishibashi et al., 1995). Instead, we generated
Hes1-deficient and control fetal-liver-derived macrophages
from day 16.5 embryos from the same pregnancy. In Hes1 null
macrophages, induction of TNF mRNA by TLR2 was comparable
to that of wild-type controls, indicating that Hes1 deficiency did
not globally alter TLR2 responses (Figure 7A, upper panel). In
contrast to TNF, TLR2-induced IL-6 and IL-27 p28 mRNA ex-
pression was augmented in Hes1-deficient macrophages
(Figure 7A). Consistent with increased amounts of IL-6 mRNA,
Hes1-deficient cells produced higher amounts of IL-6 protein
than did wild-type macrophages (Figure 7B). Similar to the
effects of Hey1, Hes1 suppressed TLR-induced IL-6-reporter
activity (Figure 7C). Overall, our results support a model of
integrated TLR and Notch signaling in which Hes1 and Hey1
fine-tune TLR responses via feedback inhibition of cytokine pro-
duction (Figure S7).
DISCUSSION
The Notch pathway has been implicated in development and
lymphocyte differentiation, whereas TLRs play a key role in acute
innate immune responses to microbial pathogens. In this study
we demonstrated synergistic cooperation between the Notch
pathway and acute TLR-induced signals in the activation of
canonical Notch target genes such as Hes1 and Hey1, and of ca-
nonical TLR-inducible genes encoding cytokines of the IL-6 and
IL-12 family. For activation of classic Notch target genes, TLRs
induced an IKK- and p38-mediated signal that cooperated with
canonical Notch signaling that was dependent on RBP-J. Con-
versely, RBP-J was required for full induction of IL-6 and IL-12700 Immunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc.in response to TLR stimulation. Our findings support a model
of cooperation between Notch and TLR pathways in the binary
activation of gene expression that is mediated by RBP-J, which
thus serves as an integration point for signaling by these two
pathways.
Activation of canonical Notch target genes and cytokine genes
was linked in a regulatory circuit, in that Hes1 and Hey1 fed back
to attenuate IL-6 and IL-12 expression. Ablation of Notch target
gene Hey1 in hematopoietic cells resulted in augmented
TLR-induced peritonitis, and diminished RBP-J expression in
macrophages attenuated endotoxin lethality, thus supporting
a physiological role for Notch-TLR crosstalk in inflammatory re-
sponses. In addition, IFN-g selectively inhibited expression of
TLR-inducible canonical Notch target genes by inhibiting
NICD2 expression and downstream Notch-mediated transcrip-
tion, thereby abrogating the Hes1- and Hey1-mediated feed-
back inhibitory loop and potentially augmenting cytokine pro-
duction. These findings provide new insights into mechanisms
by which Notch, TLR, and IFN-g signals are integrated to modu-
late specific effector functions in macrophages.
The Notch pathway is best characterized as mediating cell-cell
(juxtracrine) signaling between adjacent cells. In the immune
system, the emphasis has been on investigation of the regulation
of Notch-expressing progenitors and lymphocytes by Notch
ligands Jagged and DLL, which are expressed on stromal cells
and APCs. Our findings highlight the importance of Notch signal-
ing in APCs, in this case macrophages that express Notch li-
gands and receptors and thus have the capacity to both induce
and respond to Notch signals. The Notch pathway can be acti-
vated in macrophages in vivo by Notch ligands that are constitu-
tively or inducibly expressed by macrophages themselves, and
also by Notch ligands expressed on stromal and epithelial cells
in the marginal zone of the spleen, thymic epithelium and bone
marrow stromal cells, or stromal cells at inflammatory sites
such as rheumatoid arthritis synovium (Caton et al., 2007; Tani-
gaki and Honjo, 2007).
Immunity
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APCs can feed back on macrophages to augment NF-kB activa-
tion and TNF production (Amsen et al., 2004; Amsen et al., 2007;
Fang et al., 2007; Fung et al., 2007; Monsalve et al., 2006; Palaga
et al., 2008; Tanigaki and Honjo, 2007). In contrast, we have
shown that Notch signals, when present contemporaneously
with TLR stimulation, synergize with TLR signals to activate ca-
nonical Notch target genes and thereby regulate TLR responses
and downstream functions, such as those regulated by Hes1 and
Hey1. Thus, our work extends and modifies the current paradigm
of TLR-Notch interactions to show that there is a reciprocal rela-
tionship and that Notch signaling participates in and regulates
primary TLR responses. The functional outcome of TLR and
Notch interaction is complex given that the key Notch transcrip-
tion factor RBP-J positively regulates TLR induction of TNF, IL-6,
and IL-12, whereas Notch and RBP-J target genes Hes1 and
Hey1 negatively regulate TLR-induced IL-6 and IL-12 production
and thereby fine-tune TLR responses. The seemingly opposing
actions of Notch components and Notch target genes may not
be surprising given that, in the setting of developmental biology,
feedback inhibition by Hes and Hey proteins is well established.
The interaction of Notch and TLR pathways on cytokine gene
promoters may also be direct and mediated by RBP-J, as the
IL-6 promoter binds RBP-J (Plaisance et al., 1997) and we
have provided evidence supporting a role for RBP-J and the
IL-6 promoter RBP-J element in TLR-induced expression of IL-6.
One striking finding was that expression of Notch primary tar-
get genes was inhibited by IFN-g. IFN-g did not interrupt TLR4-
induced proximal signaling (Hu et al., 2005) but instead sup-
pressed NICD2 expression, Notch-dependent transcription,
and TLR-induced recruitment of RNA polymerase II to Notch pri-
mary target genes. IFN-g did not inhibit expression of unpro-
cessed Notch2 protein, suggesting that IFN-g either prevents
Notch2 cleavage or destabilizes the released intracellular
NICD2 fragment. The exact mechanism of regulation of NICD2
by IFN-g will be an interesting subject for future investigation.
Because a Notch-dependent input was required for effective
gene activation, suppression of Notch transcription provides
a new mechanism by which IFN-g modulates TLR responses
by specifically suppressing expression of TLR-inducible canon-
ical Notch target genes. In contrast, IFN-g is well known for its
capacity to augment TLR-induced production of cytokines in-
cluding IL-6 and IL-12. There are multiple mechanisms underly-
ing this priming effect, which appear to override any negative ef-
fects on IL-6 and IL-12 expression secondary to IFN-g-mediated
decreases in Notch-pathway activity. In addition, our results
suggest that suppression of Hes1 and Hey1 expression by
IFN-g and interruption of this Notch-dependent feedback-inhibi-
tion loop corresponds to a new mechanism by which IFN-g aug-
ments cytokine production. Interestingly, induction of Hes4 by
the Notch pathway in neural stem cells was inhibited by ciliary
neurotrophic factor (CNTF), which, similar to IFN-g, activates
the Jak-STAT pathway (Androutsellis-Theotokis et al., 2006).
Our findings, in conjunction with this report, suggest that cyto-
kines that activate the Jak-STAT pathway may more broadly
suppress Notch responses during cell activation and differentia-
tion and that the effects of IFN-g (and potentially other cytokines)
may need to be considered in investigation of the effects of the
Notch pathway on T cell differentiation.Hes and Hey inhibit transcription of primary Notch target
genes in hematopoietic progenitors by targeting E box proteins
and also inhibit genes directly by binding to conserved N box se-
quences in gene promoters (Fischer and Gessler, 2007; Iso et al.,
2003). Our results mapped inhibition of IL-6 expression to an
E box-like element in the IL-6 promoter, suggesting that Hes
and Hey proteins can inhibit expression of at least some cyto-
kines by targeting E box-mediated regulation. Future work will
determine whether IL-12 p40 and p35 promoters are inhibited
via similar mechanisms, via binding of Hes1 and Hey1 to pro-
moter N box elements, or by other or indirect mechanisms.
The functions of Hes1 and Hey1 were not redundant in our sys-
tem, possibly because these are the only two Hes and Hey family
members expressed in macrophages (X.H., unpublished data) or
because Hes1 and Hey1 function more effectively as hetero-
dimers (Iso et al., 2003). In contrast to IL-6 and IL-12, we found
that Hes1 and Hey1 did not inhibit expression of the prototypic
proinflammatory cytokines TNF and IL-1. Thus, Hes1 and Hey1
do not function to restrain TNF-mediated inflammation that is in-
duced by TLRs and augmented by the Notch-RBP-J pathway.
Our findings provide an immune function for Hes and Hey pro-
teins and suggest that they selectively regulate cytokines that
modulate the transition from innate to acquired immunity. Under-
standing mechanisms by which specific aspects of TLR re-
sponses are regulated is important for understanding the




CD14+ monocytes were purified from fresh peripheral blood mononuclear cells
(PBMCs) with anti-CD14 magnetic beads (Miltenyi Biotec) and were cultured in
RPMI 1640 medium with 10% FBS (Hyclone) and 10 ng/ml of M-CSF (Pepro-
tech). Murine bone-marrow-derived macrophages were obtained as de-
scribed (Hu et al., 2002) and maintained in DMEM supplemented with 20%
FBS and 10 ng/ml of murine M-CSF (Peprotech). For fetal-liver-derived
macrophages, fetal livers were harvested from E16.5 embryos of hes1+/ 3
hes1+/ matings (on ICR background), and homogenized liver cells were cul-
tured in DMEM supplemented with 20% FBS and 10 ng/ml of murine M-CSF
for 2 weeks. The experiments using human and murine cells were approved
by, respectively, the Hospital for Special Surgery Institutional Review Board
and Institutional Animal Care and Use Committee.
Mice
We generated mice with myeloid-specific deletion of RBP-J by crossing
Rbpjflox/flox animals (Tanigaki et al., 2002) to animals with a lysozyme-driven
Cre transgene on the C57/BL6 background (Jackson). F1 littermates with
Rbpjflox/flox or Rbpjflox/flox, Cre/Cre genotypes were used for experiments. To
generate bone marrow chimeras, we harvested donor bone marrow cells
from wild-type or Hey1/ animals (on C57/BL6 background) and one-fourth
of total bone marrow cells was injected intravenously into each of the irradiated
recipients. Recipient mice (6-week-old C57/BL6 mice) were obtained from
Jackson Laboratory and were lethally irradiated with a single dose of 875
rads 1 day prior to transplantation. Chimeric mice were sacrificed 7 weeks
after transplantation. Myeloid-specific p38a knockout mice were previously
described (Kang et al., 2008).
Reagents
Pam3Cys was purchased from EMC microcollections and R848 was from In-
vivogen. Cell-culture-grade LPSs, CHX, L685458, and SB203580 were from
Sigma-Aldrich. Compound E and Bay11-7082 were obtained from AlexisImmunity 29, 691–703, November 14, 2008 ª2008 Elsevier Inc. 701
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Integration of Notch, TLR, and IFN-g SignalingBiochemicals and Calbiochem, respectively. Recombinant Jagged1/Fc chi-
meric protein was from R&D Systems.
Analysis of mRNA and Protein
Real-time PCR, immunoblotting, and ELISA were performed as previously de-
scribed (Hu et al., 2002). Primary transcripts were measured with primers that
amplify either exon-intron junctions or intronic sequences. For Hes1 and Hey1
primary transcripts, similar results were obtained with multiple primer sets tar-
geting different regions of the same genes. For immunoblotting, Hes1 (clone
H-140), TBP, and SHP2 antibodies were from Santa Cruz Biotechnology,
and NICD1 and Stat3 antibodies were from Cell Signaling. A Notch2 antibody
developed by Dr. Artavanis-Tsakonas was obtained from the Developmental
Studies Hybridoma Bank developed under the auspices of the NICHD and
maintained by the University of Iowa, Department of Biological Sciences
(Iowa City, IA 52242, USA).
RNA Interference
Prevalidated RBPJ-, IKKB-, and MEKK3-specific short interfering RNAs
(siRNAs) and non-targeting control siRNAs were purchased from Dharmacon
and Invitrogen. siRNAs were transfected into primary human macrophages
with the Amaxa Nucleofector device set to program Y-001 using the Human
Monocyte Nucleofector kit. Comparable results were obtained when macro-
phages were transfected with Lipofectamine RNAi Max reagent (Invitrogen).
Transient-Transfection and Luciferase Assay
For Hes1 reporter gene assays, RAW264.7 cells were transfected in duplicate
in 24-well plates with a Hes1 reporter construct and an expression plasmid
encoding NICD1 or a control empty vector and an internal control plasmid
encoding renilla luciferase (Promega) with Lipofectamine Plus reagent from
Invitrogen. On the next day, cells were stimulated with LPSs for 6 hr, and
cell lysates were prepared and analyzed for firefly and renilla luciferase activity
with the Dual-Luciferase Reporter Assay System (Promega). Results were
shown as firefly normalized relative to renilla luciferase activity. For IL-6-re-
porter-gene assays, a 1.3 kb mouse IL-6 promoter fragment was subcloned
into pGL3-Basic vector (Promega). We generated deletion constructs by clon-
ing PCR products containing various fragments of the IL-6 promoter into
pGL3-Basic vector and generated point mutations by using the QuikChange
Site-directed Mutagenesis kit (Stratagene). RAW264.7 cells were transfected
with pGL3-IL6-Luc-derived reporter plasmids and an expression plasmid
encoding Hes1 or Hey1 or a control vector pCMV-XL4 (Origene) as described
for Hes1 reporter gene assays.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed with the ChIP Assay
Kit (Upstate) in accordance with the manufacturer’s instructions. A total of
10 3 106 human primary macrophages were used per condition, and 20%
of chromatin from each condition was used per IP. Antibodies against RNA
polymerase II (Santa Cruz Biotechnology), anti-phospho-histone H3 Ser10
clone MC463 (Upstate), anti-acetyl-histone H3 (Upstate), anti-total histone
H3 (Upstate), and control rabbit IgG (Santa Cruz Biotechnology) were used.




The microarray data set has been deposited with the GEO database, acces-
sion number GSE11864.
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